SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Payoneer cuts 6% of workforce as profitability pressures mount

Johny Srouji breaks silence: “I don’t plan on leaving Apple anytime soon”

Israeli cybersecurity funding soars to $4.4 billion, up 46% in 2025

“ My main argument for Israeli startups to come to Europe is it's a huge market”

Buzz

Most popular

Daily

Weekly

1

“I can retire… with peace”: Nir Zuk says Palo Alto Networks finally achieved his 20-year vision with $25B CyberArk acquisition

2

Mobileye lays off 200 employees; Company's shares down more than 40% this year

3

Johny Srouji weighs leaving Apple, raising stakes for the Israeli executive who built its silicon program

4

ZIM faces pivotal vote as company weighs at least three acquisition offers

5

Could Prompt Security be SentinelOne’s lifeline as shares slide 35% this year?

Sisram Medical

5 stories about Sisram Medical

מימין קאלואן פוסון ויליאם הו פוסום ליאור דיין מיסטר לואי

Fosun Whetted Our Appetite, Says Alma Lasers CEO

04.07.19|Golan Hazani

Fosun Pharma CEO Yifang Wu and Alma Lasers CEO Lior Dayan gave Calcalist their first joint interview since the Chinese conglomerate acquired the Israeli medical laser company in 2013

בכירי פוסון אלמא לייזרס וחברת נכסי קיסריה עם השק אלי כהן בטקס ב קיסריה

Fosun Pharma Inaugurates New Building for Israeli Subsidiary Sisram Medical

26.02.19|Golan Hazani

Fosun paid $240 million for a 95% stake in the Israeli cosmetic surgery in 2014, floating it on the Hong Kong Exchange in 2017

קיסריה קמפוס גרניט 2

Fosun Pharma Subsidiary Sisram Medical Leases 11,000-Square-Meter Building in Caesarea

10.12.18|Dotan Levy

The ten-year lease is estimated at $1.7 million (NIS 6.3 million) per year. China’s Fosun Pharma bought Sisram in 2014 for $240 million, renaming it from Alma Lasers

בורסת הונג קונג בורסה בורסות אסיה

Sisram Stock Price Down on Market Debut

19.09.17|Amarelle Wenkert

The Fosun Pharma subsidiary debuted on the Hong Kong Stock Exchange Tuesday

בורסת הונג קונג בורסה בורסות אסיה

Sisram Medical Seeks to Raise Up To $176 Million in Hong Kong IPO

10.09.17|Amarelle Wenkert

On September 5, the Fosun Pharma subsidiary submitted a prospectus to the Hong Kong Stock Exchange